Etiome Analysis: $50M Raised
What is Etiome?
Etiome develops Biostaged Medicines aimed at preventing disease progression before it becomes debilitating. The company utilizes detailed biological models to create stage-specific therapies for targeted patient populations. Their mission is to enhance health outcomes by addressing diseases at their early stages.
Location
140 First St, Cambridge, Massachusetts 02141, United States
Employees
11-50
Founded
2021
Funding Status
Series A
Product Features & Capabilities
- Biostaged Medicines for disease prevention
- Stage-specific therapies for targeted populations
Use Cases
Develop therapies to slow disease progression; Target specific patient populations with tailored treatments; Prevent irreversible damage from diseases; Address biological shifts during disease stages; Deploy medicines at optimal times for patient health
See something that needs updating? Suggest edits to this profile.